KYNTRA BIO, INC. SEC filings

Filings

1. 3KYNTRA BIO, INC.FGENOct 8

   2 insider filings

   Andrew E. Singer, new insider at FGEN

   Show all 2

   • 3New insider at FGENOct 8
   • 4Insider filing for FGENOct 8

   Andrew E. Singer, reporting

2. 8-KKYNTRA BIO, INC.FGENOct 6

   KYNTRA BIO faces delisting threat

   • Received delisting notice from Nasdaq on 9/30/2026
   • Requested hearing to challenge delisting decision
   • Previously non-compliant with Nasdaq listing rules since 4/2/2026
3. 8-KKYNTRA BIO, INC.FGENOct 1

   Current report

4. 4KYNTRA BIO, INC.FGENSep 9

   2 insider filings

   Thane Wettig, insider filing for FGEN

   Show all 2

   • 4Insider filing for FGENSep 9
   • 4Insider filing for FGENSep 9

   Thane Wettig, reporting

5. 8-KKYNTRA BIO, INC.FGENAug 31

   Current report

6. SCHEDULE 13G/AKYNTRA BIO, INC.FGENAug 14

   Ownership stake disclosure by ARMISTICE CAPITAL, LLC (amended)

   ARMISTICE CAPITAL, LLC, filed by

7. 10-QKYNTRA BIO, INC.FGENAug 13

   Quarterly report

8. 8-KKYNTRA BIO, INC.FGENAug 13

   Current report

9. 4KYNTRA BIO, INC.FGENJun 17

   4 insider filings

   Maykin Ho, insider filing for FGEN

   Show all 4

   • 4Insider filing for FGENJun 17
   • 4Insider filing for FGENJun 17
   • 4Insider filing for FGENJun 17
   • 4Insider filing for FGENJun 17

   Maykin Ho, reporting

10. 4KYNTRA BIO, INC.FGENJun 9

    2 insider filings

    Thane Wettig, insider filing for FGEN

    Show all 2

    • 4Insider filing for FGENJun 9
    • 4Insider filing for FGENJun 9

    Thane Wettig, reporting

11. 8-KKYNTRA BIO, INC.FGENJun 9

    Current report

12. 4/AKYNTRA BIO, INC.FGENMay 19

    Thane Wettig, insider filing for FGEN (amended)

    Thane Wettig, reporting

13. 4KYNTRA BIO, INC.FGENMay 18

    Thane Wettig, insider filing for FGEN

    Thane Wettig, reporting

14. SCHEDULE 13G/AKYNTRA BIO, INC.FGENMay 15

    Ownership stake disclosure by ARMISTICE CAPITAL, LLC (amended)

    ARMISTICE CAPITAL, LLC, filed by

15. 10-QKYNTRA BIO, INC.FGENMay 12

    Quarterly report

16. 8-KKYNTRA BIO, INC.FGENMay 11

    Current report

17. ARSKYNTRA BIO, INC.FGENApr 27

    Annual report to shareholders

18. DEFA14AKYNTRA BIO, INC.FGENApr 27

    Additional proxy materials

19. DEF 14AKYNTRA BIO, INC.FGENApr 27

    Proxy statement

20. 8-KKYNTRA BIO, INC.FGENApr 9

    Current report

21. 10-KKYNTRA BIO, INC.FGENMar 16

    Annual report

22. 8-KKYNTRA BIO, INC.FGENMar 16

    Current report

23. 4KYNTRA BIO, INC.FGENMar 10

    2 insider filings

    David DeLucia, insider filing for FGEN

    Show all 2

    • 4Insider filing for FGENMar 10
    • 4Insider filing for FGENMar 10

    David DeLucia, reporting

24. SCHEDULE 13G/AKYNTRA BIO, INC.FGENFeb 17

    Ownership stake disclosure by ARMISTICE CAPITAL, LLC (amended)

    ARMISTICE CAPITAL, LLC, filed by

25. 4KYNTRA BIO, INC.FGENFeb 5

    2 insider filings

    Thane Wettig, insider filing for FGEN

    Show all 2

    • 4Insider filing for FGENFeb 5
    • 4Insider filing for FGENFeb 5

    Thane Wettig, reporting

26. 8-KFIBROGEN INCFGENJan 7

    Current report

27. 4FIBROGEN INCFGENDec 9, 2025

    2 insider filings

    David DeLucia, insider filing for FGEN

    Show all 2

    • 4Insider filing for FGENDec 9, 2025
    • 4Insider filing for FGENDec 9, 2025

    David DeLucia, reporting

28. SCHEDULE 13G/AFIBROGEN INCFGENNov 14, 2025

    Armistice Capital, LLC filed a Schedule 13G/A amendment disclosing its ownership stake in FibroGen Inc. (FGEN), a biopharmaceutical company. This filing indicates Armistice Capital's continued significant investment in FibroGen, which is of interest to investors as it provides…

    ARMISTICE CAPITAL, LLC, filed by

29. 10-QFIBROGEN INCFGENNov 10, 2025

    Quarterly report

30. 8-KFIBROGEN INCFGENNov 10, 2025

    Current report

31. 8-KFIBROGEN INCFGENNov 6, 2025

    Current report

Older filings on EDGAR